This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_STOMACH_EXALLC for full statistics.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions
not C3_STOMACH
427724
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
D00.2&
Hospital discharge: ICD-9
2302A
Cause of death: ICD-10
D00.2&
Cause of death: ICD-9
2302A
Cancer registry: Topography ICD-O-3
C16
Cancer registry: Morphology ICD-O-3
ANY
Cancer registry: Behaviour codes
2
3 out of 7 registries used, show all original rules.
17
Check minimum number of events None
17
Include endpoints None
17
Remove individuals based on genotype QC
17
CD2_INSITU_STOMACH
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
Parent code in ICD-10
D00
Name in latin
Carcinoma in situ recti
Not enough data for upset plot.
Not enough data for upset table.
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of stomach
based on the number of shared cases.
Broader endpoints:
- Carcinoma in situ of stomach (controls excluding all cancers)
- Carcinoma in situ of oral cavity, oesophagus and stomach
- Carcinoma in situ of oral cavity, oesophagus and stomach (controls excluding all cancers)
- In situ neoplasms
- In situ neoplasms (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 17 | 5 | 12 |
| Unadjusted prevalence (%) | 0.00 | 0.00 | 0.01 |
| Mean age at first event (years) | 67.86 | 70.21 | 66.89 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_INSITU_STOMACH – Carcinoma in situ of stomach
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Carcinoma in situ of stomach
↥Endpoint not on priority list, no data to show.